Evidence map›Paper›PMID 41029354›Full record

ArticleBMC research notes2025

Characterization of plasmid-mediated quinolone resistant genes among uropathogenic Escherichia coli isolates in Bushehr, south of Iran.

Matin Aref, Javad Fathi, Parisa Ghazanfari, Yalda Malekzadegan, Behdokht Jamali

Abstract read
In one paragraph

Article in BMC research notes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Matin ArefDepartment of Microbiology, Kherad Institute of Higher Education, Bushehr, Iran.
Javad FathiDepartment of Bacteriology and Virology, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Parisa GhazanfariDepartment of Clinical Sciences, Shahid Bahonar University of Kerman, Kerman, Iran.
Yalda MalekzadeganDepartment of Microbiology and Parasitology, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran. malekzadeganyalda@gmail.com.
Behdokht JamaliDepartment of Microbiology, Kherad Institute of Higher Education, Bushehr, Iran. behdokhtjamali@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesUropathogenic Escherichia coli (UPEC) is important in urinary tract infection (UTI). Quinolones and fluoroquinolones are broad-spectrum antibiotics for the treatment of UTI, although some of UPEC are resistant to these antibiotics. This study aims to investigate phenotypic and genotypic characterization of plasmid-mediated quinolone resistance UPEC isolated from patients with UTI in Bushehr. In this study, 105 isolates of UPEC were identified by standard microbiological tests and the susceptibility pattern of quinolone and fluoroquinolone were determined by the disc diffusion method. PCR was used to check the presence of plasmid-mediated quinolone resistance genes.

resultsPattern of antibiotic susceptibility showed that more than 50% and 75% of isolates were resistant to fluoroquinolones and quinolones, respectively. The frequencies of qnrS and qnrB genes were 49.5% and 23.8%, respectively. Based on analysis, there was a significant relationship between the presence of the qnrB gene and resistance to ciprofloxacin, norfloxacin, ofloxacin and levofloxacin. There was a significant relationship between the presence of qnrS gene and resistance to the tested antibiotics. Our results showed a high level of resistance to fluoroquinolones. Therefore, it is necessary to treat and prevent UTI so that physicians can use alternative antibiotics to treatment of patients based on laboratory results.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialEscherichia coli InfectionsEscherichia coli ProteinsPlasmidsQuinolonesUrinary Tract InfectionsUropathogenic Escherichia coliCiprofloxacinFluoroquinolonesHumansIranMicrobial Sensitivity TestsAnti-Bacterial AgentsCiprofloxacinEscherichia coli ProteinsFluoroquinolonesQnr protein, E coliQuinolonesQuinolone resistanceUrinary tract infectionUropathogenic Escherichia coli

Identifiers

PMID41029354
PMCPMC12487233

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.